BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7069325)

  • 1. Electrophysiologic effects of mexiletine on normal and ischemic ventricles.
    Yoon MS; Han J
    J Electrocardiol; 1982 Apr; 15(2):109-13. PubMed ID: 7069325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of verapamil on ventricular rhythm during acute coronary occlusion.
    Fondacaro JD; Han J; Yoon MS
    Am Heart J; 1978 Jul; 96(1):81-6. PubMed ID: 655114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of mexiletine on the excitability and vulnerability of the dog ventricle (author's transl)].
    Márquez Montes J; Vera Almazán A; Esteve Alderete JJ; Puente Rodero B; Montero C; Castillo-Olivares JL
    Arch Farmacol Toxicol; 1981 Dec; 7(3):307-18. PubMed ID: 7337470
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacology and clinical use of mexiletine.
    Fenster PE; Comess KA
    Pharmacotherapy; 1986; 6(1):1-9. PubMed ID: 3513138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mexiletine and quinidine in combination in an ischemic model: supra-additive antiarrhythmic and electrophysiologic actions.
    Duff HJ; Gault NJ
    J Cardiovasc Pharmacol; 1986; 8(4):847-57. PubMed ID: 2427828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ventricular arrhythmias following one-stage and two-stage coronary reperfusion: evidence for both reentry and enhanced automaticity.
    Kabell G; Scherlag BJ; Brachmann J; Harrison L; Lazzara R
    J Electrocardiol; 1985 Jan; 18(1):87-96. PubMed ID: 2579181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mexiletine for recurring ventricular arrhythmias: assessment by long-term electrocardiographic recordings and sequential electrophysiologic studies.
    Flaker GC; Madigan NP; Alpert MA; Moser SA
    Am Heart J; 1984 Sep; 108(3 Pt 1):490-5. PubMed ID: 6475711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of an antiarrhythmic drug A-2545 on canine ventricular arrhythmia models; comparison with mexiletine and flecainide.
    Xue YX; Arita J; Aye NN; Hashimoto K
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Dec; 358(6):649-56. PubMed ID: 9879724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Electrophysiologic actions of mexiletine (Kö-1173) in man].
    González Maqueda I; García Fernández F; Martín Jadraque L
    Med Clin (Barc); 1981 Mar; 76(5):223-5. PubMed ID: 7206892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of mexiletine on monophasic action potentials recorded from the right ventricle in man.
    Harper RW; Olsson SB; Varnauskas E
    Cardiovasc Res; 1979 Jun; 13(6):303-10. PubMed ID: 476751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of mexiletine on conduction of premature ventricular beats in man: a study using monophasic action potential recordings from the right ventricle.
    Harper RW; Olsson SB
    Cardiovasc Res; 1979 Jun; 13(6):311-9. PubMed ID: 476752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophysiological actions of mexiletine on isolated rabbit atria and canine ventricular muscle and purkinje fibres.
    Yamaguchi I; Singh BN; Mandel WJ
    Cardiovasc Res; 1979 May; 13(5):288-96. PubMed ID: 476749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophysiologic effects of mexiletine in children.
    Shakibi JG; Moezzi B
    Jpn Heart J; 1982 Sep; 23(5):733-8. PubMed ID: 7176082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of mexiletine on the electrophysical properties of the intact human heart.
    Harper RW; Olsson SB; Varnauskas E
    Scand J Clin Lab Invest; 1977 Oct; 37(6):503-7. PubMed ID: 616069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arrhythmogenic effects of mexiletine in infarcted Purkinje tissues.
    Han J; Derhsam GH; O'Connell DP
    J Electrocardiol; 1989 Jan; 22(1):81-7. PubMed ID: 2921581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mexiletine action on the specialized tissues of the human heart.
    Pozzoni L; Romano S; Beltrami A; Calosso E; Verzoni A; Longoni A; Croce L
    Int J Clin Pharmacol Res; 1985; 5(4):229-36. PubMed ID: 4055166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of oral mexiletine on left and right ventricular function.
    Stein J; Podrid P; Lown B
    Am J Cardiol; 1984 Sep; 54(6):575-8. PubMed ID: 6475776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrophysiological mechanisms for the antiarrhythmic action of mexiletine on digitalis-, reperfusion- and reoxygenation-induced arrhythmias.
    Amerini S; Carbonin P; Cerbai E; Giotti A; Mugelli A; Pahor M
    Br J Pharmacol; 1985 Dec; 86(4):805-15. PubMed ID: 4075017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of arrhythmias and of antiarrythmic activity, with special reference to mexiletine.
    Carmeliet E
    Acta Cardiol Suppl; 1980; (25):5-25. PubMed ID: 6246694
    [No Abstract]   [Full Text] [Related]  

  • 20. Electrophysiologic effects and clinical efficacy of mexiletine used alone or in combination with class IA agents for refractory recurrent ventricular tachycardias or ventricular fibrillation.
    Kim SG; Felder SD; Waspe LE; Fisher JD
    Am J Cardiol; 1986 Sep; 58(6):485-90. PubMed ID: 3529910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.